Welcome to our dedicated page for Columbia Financ SEC filings (Ticker: CLBK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Columbia Financial, Inc. (NASDAQ: CLBK), the mid-tier holding company for Columbia Bank. Through these filings, investors can review detailed disclosures on the company’s financial condition, results of operations, capital management, and significant corporate events.
Columbia Financial, Inc. uses current reports on Form 8-K to announce material events. Recent 8-K filings have covered quarterly earnings releases, including financial results for periods ended March 31, June 30, and September 30, as well as the year ended December 31. These filings typically reference press releases furnished as exhibits that discuss net interest income, interest expense on deposits and borrowings, provision for credit losses, non-interest income and expense, net interest margin, and overall net income or loss.
Other 8-K filings describe corporate actions and governance matters. For example, the company has filed 8-Ks regarding authorization of a stock repurchase program to acquire up to 1,800,000 shares of common stock, including details on regulatory non-objection, permitted repurchase methods, and program terms. Additional 8-Ks disclose executive officer changes, such as the planned end date of employment for a Senior Executive Vice President and Chief Operating Officer, and the availability of investor presentations outlining operating and growth strategies.
Annual reports on Form 10-K and quarterly reports on Form 10-Q, when accessed alongside these current reports, provide comprehensive information on Columbia Financial, Inc.’s loan portfolio composition, deposit base, funding sources, balance sheet repositioning transactions, asset quality metrics, and risk factors. These filings also describe the company’s structure as a Delaware corporation and majority-owned subsidiary of Columbia Bank, MHC, and its role as the holding company for Columbia Bank, a federally chartered savings bank headquartered in Fair Lawn, New Jersey.
Stock Titan’s platform enhances these filings by delivering real-time updates from the SEC’s EDGAR system and AI-powered summaries that highlight key points from lengthy documents. Users can quickly identify important information in 10-K and 10-Q reports, track material events reported on Form 8-K, and review disclosures related to capital actions such as stock repurchase programs. Insider transaction reports on Form 4, where available, can also be monitored to see reported purchases and sales by directors and executive officers.
By combining Columbia Financial, Inc.’s official SEC filings with AI-generated insights, this page helps readers understand how the company describes its performance, strategy, and risk profile in its own regulatory disclosures.
Columbia Financial, Inc. approved new two-year employment agreements for five senior executives, effective April 1, 2026, with automatic one-year renewals each April 1 unless either party gives timely notice.
The agreements set 2026 base salaries of $700,000 for Dennis E. Gibney, $470,000 for Allyson Schlesinger, $445,000 for John Klimowich, $440,000 for Oliver E. Lewis, Jr., and $430,000 for Manesh Prabhu. Executives are eligible for annual Target Bonuses, long‑term equity awards under the company's LTIP and equity plan, and participation in standard benefit and expense reimbursement programs.
If employment is terminated without cause, each executive receives cash severance equal to two times base salary plus Target Bonus and continued health coverage support. If termination without cause or resignation for good reason occurs within 24 months after a change in control, cash severance increases to three times base salary plus Target Bonus, an additional prior‑year bonus amount, and a lump sum for 36 months of continued medical, vision, and dental coverage. The agreements also provide one‑times salary‑plus‑bonus payments upon death or disability and include 24‑month non‑competition and non‑solicitation covenants, perpetual confidentiality, and mutual non‑disparagement.
Columbia Financial, Inc. named Thomas F. Splaine, Jr., its Executive Vice President and Chief Financial Officer, as the company’s principal financial officer and principal accounting officer for U.S. Securities and Exchange Commission reporting matters, effective April 17, 2026.
The filing notes that Mr. Splaine had previously been appointed Executive Vice President and Chief Financial Officer effective January 28, 2026, following the promotion of Dennis E. Gibney to First Senior Executive Vice President and Chief Banking Officer. The report also includes a standard exhibit for the cover page interactive data file.
Columbia Financial, Inc. executive John Klimowich reported updated holdings and a small equity award. As SEVP & Chief Risk Officer, he indirectly acquired 36.8869 shares of Common Stock on a stock-based deferral plan at $18.56 per share, bringing that plan’s balance to 9,042.1358 shares. The filing also lists his other indirect Common Stock holdings across stock awards, retirement and benefit plans, and 61,464 directly held Common Stock shares. In addition, he holds several stock option grants on Common Stock with exercise prices between $15.60 and $18.28, expiring from 2029 to 2036, granted under the 2019 Equity Incentive Plan.
Columbia Financial, Inc. President & CEO Thomas J. Kemly reported a small stock-based award under a deferral plan. On April 17, 2026, he acquired 100.091 shares of Common Stock at $18.56 per share indirectly through the Columbia Bank Stock-Based Deferral Plan.
This award increased his indirect holdings in that deferral plan to 69,139.4863 shares. The filing also updates indirect balances held through various stock award programs, retirement and benefit plans, and shows he directly holds 238,416 Common shares plus several option grants over Columbia Financial stock at exercise prices between $15.60 and $18.28 per share.
Columbia Financial, Inc. reported stronger first quarter results, with net income rising to $13.1 million, or $0.13 per share, for the three months ended March 31, 2026, up from $8.9 million, or $0.09 per share, a year earlier. Performance improved mainly due to a $10.1 million increase in net interest income, a lower provision for credit losses, and an expanded net interest margin of 2.42% versus 2.11% in the prior-year quarter. Non-interest income declined and expenses rose, including $1.8 million of merger-related costs, while the effective tax rate increased. Credit quality remained solid with net recoveries of $604,000, although non-performing loans increased to $41.4 million, or 0.50% of total gross loans. Total assets were stable at about $11.0 billion, deposits declined modestly, and borrowings increased. Management highlighted a previously announced second-step conversion and a planned merger with Northfield Bancorp, Inc., which are intended to expand the franchise and remain subject to regulatory, stockholder and member approvals.
Torres Daria Stacy-Walls reported acquisition or exercise transactions in this Form 4 filing.
Columbia Financial, Inc. director Daria Stacy-Walls reported a stock-based compensation grant rather than an open-market trade. On the Columbia Bank Stock Based Deferral Plan, a trustee purchased 274.6479 phantom stock units at $17.75 per unit on a non-discretionary basis. These stock unit interests will be settled in shares upon future distribution to her. Following this transaction, she holds 28,598.5752 common shares indirectly through the deferral plan and 11,255 common shares directly, plus 2,952 indirect Stock Awards that vest on March 12, 2027.
Columbia Financial, Inc. President & CEO Thomas J. Kemly received a grant of 104.6586 shares of common stock at $17.75 per share through a stock-based deferral plan, recorded as phantom stock units to be settled in shares. Following this grant, his indirect holdings under the stock-based deferral plan total 69,039.3953 units. The filing also lists substantial stock option holdings on Columbia Financial common stock with exercise prices between $15.60 and $18.28 and expirations from 2029 to 2036, reflecting ongoing equity-based compensation rather than open‑market buying or selling.
Columbia Financial, Inc. director Noel R. Holland reported an automatic stock-based award linked to the company’s deferral plan. Holland acquired 9.6011 phantom stock units of common stock at $17.75 per unit through the Columbia Bank Stock Based Deferral Plan.
After this grant, Holland holds 10,039.9776 units in the deferral plan, which will be settled in shares of stock upon distribution. The filing also shows 36,726 shares of common stock held directly, 46,280 shares held via a SEP-IRA, and 2,952 shares from a stock award, plus fully vested options covering 83,294 shares at a $15.60 exercise price expiring on July 23, 2029.
Columbia Financial, Inc. executive John Klimowich, SEVP & Chief Risk Officer, acquired 38.5701 phantom stock units of Common Stock on April 6, 2026 at $17.75 per unit through the Columbia Bank Stock Based Deferral Plan. These stock unit interests will be settled in shares upon distribution to him, bringing his balance in this stock-based deferral arrangement to 9,005.2489 units held indirectly.
The filing also lists his existing equity exposure, including directly held Common Stock and several grants of fully vested and time- or performance-vested Stock Options under the 2019 Equity Incentive Plan, such as options over 188,235 underlying shares at an exercise price of $15.60 expiring on July 23, 2029.
Columbia Financial, Inc. executive John Klimowich, SEVP & Chief Risk Officer, reported a compensation-related acquisition of 39.7804 shares of Common Stock at $17.2100 per share on March 20, 2026. The shares are phantom stock credited under the Columbia Bank Stock Based Deferral Plan and will be settled in stock upon distribution.